Drug Treatment as HIV Prevention: Expanding Treatment Options
- 202 Downloads
Research conducted during the first 20 years of the AIDS epidemic provided a solid foundation of data supporting methadone treatment as HIV prevention. Drug users in methadone treatment were consistently found to reduce the frequency of drug use, risk behaviors, and infections. These data have been consistent over time and across cultural settings and have been used to promote the expansion of drug treatment as a prevention intervention. More recently, data have emerged suggesting the prevention potential of medication-assisted treatments other than methadone (buprenorphine/naloxone and naltrexone). Still, with a few notable exceptions, global drug treatment coverage for opiate injectors remains remarkably low and only a few treatment interventions for stimulant use have shown efficacy in reducing HIV risk. Importantly, more recent data provide support for the role of drug treatment programs in improving access and adherence to antiretroviral treatment and that injection drug users in substance abuse treatment are more likely to achieve sustained viral suppression. While important challenges remain in maximizing its impact, the scientific literature provides strong evidence of the efficacy of drug treatment as an HIV prevention strategy.
KeywordsSubstance abuse treatment HIV prevention Methadone Naltrexone Buprenorphine
Preparation of this manuscript was supported in part by the following grants: U01-AI-048014, Penn Prevention Clinical Trials Unit (Metzger, PI); RO1-DA-026344-01A1 (Metzger, PI); and 6-P30-AI-45008 (Hoxie, PI).
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 1.Metzger DS, Navaline H, Woody GE: Drug abuse treatment as AIDS prevention. Public Health 1999, 113:97–106.Google Scholar
- 7.Metzger DS, Woody GE, McLellan AT, et al.: Human-immunodeficiency-virus seroconversion among intravenous-drug-users in-of-treatment and out-of-treatment - an 18-month prospective follow-up. J Acquir Immune Defic Syndr Hum Retrovirol 1993, 6:1049–1056.Google Scholar
- 9.Avants SK, Margolin A, Sindelar JL, et al.: Day treatment versus enhanced standard methadone services for opioid-dependent patients: A comparison of clinical efficacy and cost. Am J Psych 1999, 156:27–33.Google Scholar
- 13.Thiede H, Hagan H, Murrill CS: Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health Bull N Y Acad Med 2000, 77:331–345.Google Scholar
- 14.World Health Organization: AIDS epidemic update: November 2009. WHO Library Cataloguing-in-Publication Data.Google Scholar
- 22.Meade CS, Weiss RD, Fitzmaurice GM, et al.: HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA Clinical Trials Network Multisite Study. J Acquir Immune Defic Syndr 2010, In press.Google Scholar
- 34.•• Roux P, Carrieri MP, Villes V, et al.: The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008, 103:1828–1836. This article is the first to demonstrate that the beneficial effects of medication-assisted treatment on adherence to antiretroviral treatment are only seen among those who respond to treatment and cease injection. For those in drug treatment who continue to inject drugs, adherence is similar to injectors not in drug treatment.CrossRefPubMedGoogle Scholar
- 43.•• Meader N, Li R, Des Jarlais DC, Pilling S: Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev 2010, 1:CD007192. This article reports on a comprehensive meta-analysis of the published literature on psychosocial interventions to reduce risk behaviors among drug users. The conclusions of this article are that psychosocial interventions alone have only moderate evidence of efficacy. The findings support the importance of linking psychosocial interventions to efficacious interventions such as drug treatment, antiretroviral treatment, and needle exchange programs.PubMedGoogle Scholar
- 47.•• Mathers BM, Degenhardt L, Ali H, et al.: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010, 375:1014–1028. This article provides current estimates of the prevention, drug treatment, and HIV treatment services available to drug users globally. The message is clear and sobering—in all regions of the world needs for services far outstrip the availability of those services. These data support the need to both expand coverage of existing treatment strategies and to develop new approaches that are acceptable, accessible, and affordable.CrossRefPubMedGoogle Scholar